Health Care Disparities in Pulmonary Arterial Hypertension

Roberto J Bernardo; Vinicio A de Jesus Perez

doi:10.1016/j.ccm.2023.03.010

Health Care Disparities in Pulmonary Arterial Hypertension

Clin Chest Med. 2023 Sep;44(3):543-554. doi: 10.1016/j.ccm.2023.03.010. Epub 2023 May 23.

Authors

Roberto J Bernardo¹, Vinicio A de Jesus Perez²

Affiliations

¹ Division of Pulmonary, Critical Care and Sleep Medicine, University of Oklahoma Health Sciences Center, 800 Stanton L. Young Boulevard, Suite 8400, Oklahoma City, OK 73104, USA.
² Division of Pulmonary and Critical Care Medicine, Stanford University School of Medicine, 300 Pasteur Drive, Grant S140B, Stanford, CA 94305, USA; Vera Moulton Wall Center for Pulmonary Disease at Stanford University, Stanford, CA, USA. Electronic address: vdejesus@stanford.edu.

Abstract

The current approach for the management of pulmonary arterial hypertension (PAH) relies on data gathered from clinical trials and large registries. However, there is concern that minorities including Black, Indigenous, and People of Color are underrepresented in these trials and registries, making current data not generalizable to these groups of patients. Hence, it is important to discuss the significance of race/ethnicity and socioeconomic factors in patients with PAH. Here, we review the current knowledge on health care disparities in PAH. We also propose future steps in the global task of assuring justice and equality in access to pulmonary hypertension health care.

Keywords: Ethnicity; Health care disparities; Pulmonary hypertension; Social determinants of health.

Health Care Disparities in Pulmonary Arterial Hypertension

Authors

Affiliations

Abstract

Publication types

MeSH terms

Grants and funding